{"id":12555,"date":"2011-01-01T00:00:00","date_gmt":"2011-01-01T00:00:00","guid":{"rendered":"http:\/\/www.pharma-mkting.com\/uncategorized\/show041\/"},"modified":"2011-01-01T00:00:00","modified_gmt":"2011-01-01T00:00:00","slug":"show041","status":"publish","type":"post","link":"http:\/\/ec2-54-175-84-28.compute-1.amazonaws.com\/pharma-mkting.com\/talk\/show041\/","title":{"rendered":"Pharma Marketing Talk: Adherence: The Achilles Heel of Drug Efficacy"},"content":{"rendered":"

Adherence: The Achilles Heel of Drug Efficacy Click Here for Additional Resources<\/a><\/p>\n

A conversation with Vesta Brue<\/b> (see bio<\/a>), CEO of MedSignals, which developed and markets a 4-drug portable med-minding device. <\/p>\n

Aired LIVE on: <\/p>\n

Wednesday, January 23, 2008<\/b> <\/p>\nBackground<\/b><\/p>\n

Lack of adherence–the combined effect of compliance and persistence–is a big problem for the pharmaceutical industry. In the U.S. alone, the revenue loss due to medication non-adherence is $84 billion. As an example, the per capita spending on diabetes treatment in the U.S. is about $12,000. The majority of that–$7,000–is wasted due to non-adherence. <\/p>\n

A new communicating pillbox holds promise for ending the guessing game about drug adherence. The 4-drug portable MedSignals\u00ae aids patients in remembering at pill time, records timing of lid openings, uploads usage data daily to host servers, and then reveals adherence patterns to authorized caregivers keeping an eye on patient charts on the web. The MedSignals device was first developed by LIFETECHniques, a privately-owned R&D incubator that invents and tests technologies to help people self-manage difficult health behaviors. <\/p>\n

In this Live Podcast and Chat, Ms. Brue will be talking about the problem of adherence and her company’s solution to that problem..<\/p>\nQuestions\/Topics To Be Discussed<\/b> <\/p>\n